Production and applications of copper-64 radiopharmaceuticals

Methods Enzymol. 2004:386:237-61. doi: 10.1016/S0076-6879(04)86011-7.
No abstract available

MeSH terms

  • Animals
  • Antibodies / chemistry
  • Antibodies / therapeutic use
  • Antigen-Antibody Reactions
  • Chelating Agents / chemistry*
  • Copper Radioisotopes / chemistry*
  • Cyclotrons
  • Half-Life
  • Heterocyclic Compounds / chemical synthesis
  • Heterocyclic Compounds / chemistry
  • Heterocyclic Compounds, 1-Ring / chemistry
  • Humans
  • Immunoconjugates / chemistry
  • Immunoconjugates / pharmacokinetics
  • Immunoconjugates / therapeutic use
  • Nickel / chemistry
  • Nuclear Medicine
  • Organometallic Compounds / chemical synthesis
  • Organometallic Compounds / chemistry
  • Peptides / chemistry
  • Peptides / therapeutic use
  • Radioligand Assay
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / therapeutic use
  • Somatostatin / analogs & derivatives
  • Somatostatin / chemistry
  • Tissue Distribution
  • Tomography, Emission-Computed

Substances

  • Antibodies
  • Chelating Agents
  • Copper Radioisotopes
  • Heterocyclic Compounds
  • Heterocyclic Compounds, 1-Ring
  • Immunoconjugates
  • Organometallic Compounds
  • Peptides
  • Radiopharmaceuticals
  • copper(II)-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Somatostatin
  • Nickel